Bright Minds Biosciences to Present at AES 2024 Meeting
Ticker: DRUG · Form: 6-K · Filed: Nov 21, 2024 · CIK: 1827401
| Field | Detail |
|---|---|
| Company | Bright Minds Biosciences INC. (DRUG) |
| Form Type | 6-K |
| Filed Date | Nov 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: conference-presentation, biotech, data-release
Related Tickers: BMBS
TL;DR
BMBS presenting epilepsy data at AES 2024 meeting. Good sign for pipeline.
AI Summary
Bright Minds Biosciences Inc. announced on November 21, 2024, that it will present data at the American Epilepsy Society 2024 Annual Meeting. The company, located at 19 Vestry Street, New York, NY 10013, filed this Form 6-K report.
Why It Matters
Presenting data at a major industry conference like the American Epilepsy Society meeting can generate interest and potentially validate the company's research and development efforts.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a presentation at a conference, with no immediate financial or operational changes disclosed.
Key Players & Entities
- Bright Minds Biosciences Inc. (company) — Registrant
- American Epilepsy Society 2024 Annual Meeting (event) — Presentation Venue
- November 21, 2024 (date) — Announcement Date
- Ryan Cheung (person) — Chief
FAQ
What specific data will Bright Minds Biosciences present at the American Epilepsy Society 2024 Annual Meeting?
The filing does not specify the exact data to be presented, only that data will be presented.
When is the American Epilepsy Society 2024 Annual Meeting scheduled to take place?
The filing does not provide the dates for the American Epilepsy Society 2024 Annual Meeting.
Who is Ryan Cheung and what is his role at Bright Minds Biosciences Inc.?
Ryan Cheung is identified as 'Chief' and signed the report on behalf of Bright Minds Biosciences Inc.
What is the principal executive office address for Bright Minds Biosciences Inc.?
The principal executive office is located at 19 Vestry Street, New York, NY 10013.
What type of report is this Form 6-K filing?
This is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Stats: 174 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2024-11-21 11:30:03
Filing Documents
- form6k.htm (6-K) — 3KB
- exhibit99-1.htm (EX-99.1) — 10KB
- exhibit99-1x001.jpg (GRAPHIC) — 3KB
- 0001062993-24-019452.txt ( ) — 19KB
From the Filing
Bright Minds Biosciences Inc.: Form 6-K - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File No. 001-40997 BRIGHT MINDS BIOSCIENCES INC. (Translation of registrant's name into English) 19 Vestry Street, New York, NY 10013 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F [ X ] Form 40-F [ ] SUBMITTED HEREWITH Exhibits 99.1 News Release dated November 21, 2024 re: Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BRIGHT MINDS BIOSCIENCES INC. /s/ Ryan Cheung __________________________ Ryan Cheung Chief Financial Officer Date: November 21, 2024